Magnus T Dillon

5PUBLICATIONS

36CO-AUTHORS

Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 27, 2026

Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer Centre Experience.

|Aug 06, 2025

Interfaces Between the DNA Damage Response and Anti-cancer Immunity.

Charleen Chan Wah Hak, Magnus Dillon

|Aug 01, 2025

Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.

Magnus T Dillon, Emmanuel C Patin, Kabir Mohammed

|Jul 08, 2025

The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

|Aug 12, 2024

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy.

Emmanuel C Patin, Pablo Nenclares, Charleen Chan Wah Hak

Pageof 1

Frequent Collaborators

Kevin J Harrington

Alan Melcher

Emmanuel C Patin

Pablo Nenclares

Simon A Smith

Christopher J Lord

Antonio Rullan

Shane Foo

Charleen Chan Wah Hak

1 joint publications

Katharine Aitken

Frequent Collaborators

Kevin J Harrington

Alan Melcher

Emmanuel C Patin

Pablo Nenclares